Polocaine-mpf Injection, Solution
Product Images NDC 63323-293

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Polocaine-mpf (NDC 63323-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pol09 0001 01

Chemical structure of mepivacaine hydrochloride, illustrating the molecular arrangement including a piperidine ring with a methyl substitution and an aromatic ring substituted with methyl groups, associated with hydrochloride.*

FDA Label Image

Pol09 0001 02

FDA Label Image

Pol09 0001 03

Label for Polocaine-MPF (mepivacaine HCl Injection, USP) 1% injection solution, containing 10 mg/mL strength. It is a 30 mL single-dose vial labeled for nerve block, caudal, epidural, and infiltration anesthesia. The product is methylparaben free and distributed by Fresenius Kabi USA, LLC. Storage instructions specify controlled room temperature (20° to 25°C). Rx only.*

FDA Label Image

Pol09 0001 04

Label for Polocaine-MPF (mepivacaine HCl injection, USP) 1% solution, 300 mg per 30 mL (10 mg/mL), provided as 25 single-dose vials of 30 mL each. The label states it is for nerve block, caudal, epidural, and infiltration anesthesia, but not for spinal anesthesia or dental use. It is methylparaben free, preservative free, and intended for prescription use only. The label lists ingredient quantities, storage conditions, manufacturer Fresenius Kabi USA, LLC, and includes the NDC 63323-260-37.*

FDA Label Image

Pol09 0001 05

Label for Polocaine (mepivacaine HCl Injection, USP) 1% solution, containing 10 mg/mL of active ingredient in a 50 mL multiple dose vial by Fresenius Kabi USA, LLC. The label states storage conditions, usage for infiltration and nerve block only, and that it is not intended for spinal anesthesia or dental use.*

FDA Label Image

Pol09 0001 06

Polocaine 1% (mepivacaine HCl Injection, USP) 500 mg per 50 mL (10 mg/mL) solution for injection, indicated for infiltration and nerve block only. The label includes ingredients per mL, storage instructions, and notes that it is not for spinal anesthesia or dental use. Package contains 25 multiple dose vials of 50 mL each. Labeler: Fresenius Kabi USA, LLC.*

FDA Label Image

Pol09 0001 07

Label for Polocaine-MPF injection, containing mepivacaine hydrochloride at 15 mg/mL concentration (1.5%), with a total of 450 mg per 30 mL in a single-dose vial. Indicated for nerve block, caudal, epidural, and infiltration anesthesia. The label notes methylparaben-free formulation, storage instructions at 20° to 25°C, and the product is Rx only. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Pol09 0001 08

Polocaine-MPF 1.5% injection, containing 15 mg/mL mepivacaine hydrochloride, in a 30 mL single-dose vial (450 mg per vial). The label notes use for nerve block, caudal, epidural, and infiltration anesthesia, excluding spinal anesthesia or dental use. It is methylparaben-free, preservative-free, and produced by Fresenius Kabi USA, LLC.*

FDA Label Image

Pol09 0001 09

Polocaine MPF 2% injection solution label showing mepivacaine hydrochloride at 20 mg/mL concentration in a 20 mL single dose vial. Indicated for nerve block, caudal, epidural, and infiltration anesthesia by Fresenius Kabi USA, LLC. Storage instructions specify 20° to 25°C controlled room temperature. Label includes lot and expiration information and is RX only.*

FDA Label Image

Pol09 0001 10

Polocaine-MPF 20 mg/mL (2%) mepivacaine hydrochloride injection, USP solution for infiltration anesthesia in single-dose 20 mL vials. The label indicates 25 vials per package, no preservatives, methylparaben free, for nerve block, caudal and epidural anesthesia, not for spinal or dental use. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Pol09 0001 11

Label for Polocaine (mepivacaine HCl Injection, USP) 2% solution, with a concentration of 20 mg per mL in a 50 mL multiple dose vial. The label states it is for infiltration and nerve block only, not for spinal anesthesia or dental use. The product is labeled by Fresenius Kabi USA, LLC, with storage instructions at 20° to 25°C.*

FDA Label Image

Pol09 0001 12

Label for Polocaine (mepivacaine HCl Injection, USP) 2% injection solution, 20 mg/mL strength, in a 50 mL multiple dose vial pack of 25 vials. Indicated for infiltration and nerve block only. Manufactured by Fresenius Kabi USA, LLC. Includes storage instructions and ingredient details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.